Allarity Therapeutics Inc Share Price Today: Live Updates & Key Insights

Allarity Therapeutics Inc share price today is $1.19, up -2.46%. The stock opened at $1.21 against the previous close of $1.22, with an intraday high of $1.22 and low of $1.19.

Allarity Therapeutics Inc Share Price Chart

Allarity Therapeutics Inc

us-stock
To Invest in {{usstockname}}
us-stock

Allarity Therapeutics Inc Share Price Performance

$1.19 -0.0246(-2.46%) ALLR at 27 Jul 2026 01:55 PM Biotechnology
Lowest Today 1.19
Highest Today 1.22
Today’s Open 1.21
Prev. Close 1.22
52 Week High 2.06
52 Week Low 0.77
Day’s Range: Low 1.19 High 1.22
52-Week Range: Low 0.77 High 2.06
1 day return -
1 Week return +1.28
1 month return -8.52
3 month return -13.86
6 month return -0.42
1 year return +5.82
3 year return -97.8
5 year return -99.99
10 year return -

Allarity Therapeutics Inc Institutional Holdings

Vanguard Group Inc 1.55

Renaissance Technologies Corp 1.43

Geode Capital Management, LLC 1.20

Vanguard Capital Management, LLC 1.08

Vanguard Institutional Extnd Mkt Idx Tr 1.08

State Street Corp 0.86

Fidelity Extended Market Index 0.59

Vanguard Fiduciary Trust Co 0.47

Northern Trust Corp 0.30

XTX Topco Ltd 0.18

Two Sigma Investments LLC 0.17

UBS Group AG 0.15

Fidelity Total Market Index 0.14

Fidelity Series Total Market Index 0.14

Northern Trust Extended Eq Market Idx 0.12

NT Ext Equity Mkt Index Fund - Lending 0.12

Spartan Extended Market Index Pool F 0.11

NT Ext Equity Mkt Index Fund - NL 0.11

TWO SIGMA SECURITIES, LLC 0.08

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.08

Spartan Total Market Index Pool G 0.06

Citigroup Inc 0.05

NT Ext Eq Mkt Idx Fd DC Lending Tier 5 0.05

Northern Trust Wilshire 5000 0.00

NT US Market Cap Index Fund - Ld 0.00

Advisor Group Holdings, Inc. 0.00

Caitong International Asset Management Co., Limited. 0.00

Capital Advisors, Inc. 0.00

Citadel Advisors Llc 0.00

Danske Bank A/S. 0.00

DRW Securities, LLC 0.00

JONES FINANCIAL COMPANIES LLLP 0.00

Private Advisor Group, LLC 0.00

Allarity Therapeutics Inc Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Allarity Therapeutics Inc Fundamentals

Market Cap 19.41 M

PB Ratio 2.9315

PE Ratio 0.0

Enterprise Value 22.05 M

Total Assets 18.26 M

Volume 43888

Allarity Therapeutics Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:120000 0.1M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:120000 0.1M

Annual Net worth FY23:-13017000 -13.0M, FY22:-16058000 -16.1M, FY21:-26648000 -26.6M, FY20:-5073000 -5.1M, FY19:-14400000 -14.4M

Quarterly Revenue Q1/2026:25000 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:51000 0.1M, Q3/2025:null 0.0M, Q2/2025:-12000 -0.0M, Q1/2025:-11000 -0.0M, Q3/2024:null 0.0M

Quarterly Net worth Q1/2026:-2750000 -2.8M, Q3/2025:-2806000 -2.8M, Q2/2025:-2320000 -2.3M, Q1/2025:-2732000 -2.7M, Q3/2024:-12152000 -12.2M

About Allarity Therapeutics Inc & investment objective

Company Information Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced and recurrent ovarian cancer. It is also developing stenoparib with temozolomide, a PARP and WNT inhibitor in combination with a DNA-alkylating chemotherapy agent, which is in a Phase 2 clinical trial for patients with relapsed small cell lung cancer; and stenoparib-DRP, a companion diagnostic product used to select patients for stenoparib treatment. Allarity Therapeutics, Inc. is headquartered in Tarpon Springs, Florida.

Organisation Biotechnology

Employees 7

Industry Biotechnology

CEO Mr. Thomas H. Jensen

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Allarity Therapeutics Inc FAQs

What is the share price of Allarity Therapeutics Inc today?

The current share price of Allarity Therapeutics Inc is $1.19.

Can I buy Allarity Therapeutics Inc shares in India?

Yes, Indian investors can buy Allarity Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Allarity Therapeutics Inc shares in India?

You can easily invest in Allarity Therapeutics Inc shares from India by:

Can I buy fractional shares of Allarity Therapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Allarity Therapeutics Inc?

Allarity Therapeutics Inc has a market cap of $19.41 M.

In which sector does Allarity Therapeutics Inc belong?

Allarity Therapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in Allarity Therapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Allarity Therapeutics Inc?

The PE ratio of Allarity Therapeutics Inc is N/A and the PB ratio is 2.93.